Elsevier Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Hsu
    Hsu
  3. Kris
    Kris
  4. Berger
    Berger
  5. Giralt
    Giralt
  6. Perales
    Perales
  7. Riely
    Riely
  8. Hanash
    Hanash
  9. Peled
    Peled
  10. Solit
    Solit

Groups

  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)
  7. Center for Hematologic Malignancies (166)
  8. Hematologic Malignancies, Division of (151)
  9. Sloan Kettering Institute Postdocs (125)
  10. Bone Marrow Transplant (116)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (182)
  3. Review (14)
  4. Book Section (9)
  5. Editorial (8)
  6. Conference Paper (1)
  7. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)

More Groups

People
  1. Marc Ladanyi (97)
  2. Marcel Van Den Brink (61)
  3. Katharine Hsu (52)
  4. Mark Kris (44)
  5. Michael Berger (38)
  6. Miguel-Angel Perales (37)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (26)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (100)
  2. Journal of Thoracic Oncology (89)
  3. Urologic Oncology: Seminars and Original Investigations (31)
  4. European Journal of Cancer (30)
  5. International Journal of Radiation Oncology, Biology, Physics (18)
  6. Transplantation and Cellular Therapy (13)

More Publications

Results (420)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Identifying early and late hallmarks of plasticity in neuroendocrine transformation of lung cancer at single-cell level
    Meeting Abstract

    Chan, J. M.; Quintanal-Villalonga, A.; Sabet, A.; Manoj, P.; Masilionis, I.; Falcon, C.; Sohail, N.; Chun, J.; Nawy, T.; Mazutis, L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Exportin 1 inhibition constraints lineage plasticity and histological transformation through downregulation of SOX2
    Meeting Abstract

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shaffer, M.; Manoj, P.; Sridhar, H.; Haffner, M. C.; Sawyers, C. L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in NSCLC
    Journal Article

    Alessi, J. V.; Wang, X.; Elkrief, A.; Ricciuti, B.; Li, Y. Y.; Gupta, H.; Spurr, L. F.; Rizvi, H.; Luo, J.; Pecci, F.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy
    Journal Article

    Khaleel, S.; Truong, H.; Jiang, S.; K-Lee, P.; Davelman, B.; Gordon, D.; Benfante, N.; Arora, A.; Ostrovnaya, I.; Tickoo, S.; more...
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: An observational cohort study
    Journal Article

    Bertsimas, D.; Margonis, G. A.; Tang, S.; Koulouras, A.; Antonescu, C. R.; Brennan, M. F.; Martin-Broto, J.; Rutkowski, P.; Stasinos, G.; Wang, J.; more...
    eClinicalMedicine (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
    Journal Article

    Gelderblom, H.; Jones, R. L.; Blay, J. Y.; George, S.; von Mehren, M.; Zalcberg, J. R.; Kang, Y. K.; Razak, A. A.; Trent, J.; Attia, S.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save